Oral contraceptive use has been associated with risk of Crohn's disease (CD) and ulcerative colitis (UC).
Objective
To determine whether this association is confounded or modified by other important lifestyle and reproductive factors.
Design
A prospective cohort study was carried out of 117,375 US women enrolled since 1976 in the Nurses Health Study I (NHS I) and 115,077 women enrolled since 1989 in the Nurses' Health Study II (NHS II) with no prior history of UC or CD. These women had provided information every 2 years, on age at menarche, oral contraceptive use, parity, menopause status and other risk factors. Diagnoses of CD and UC were confirmed by review of medical records. Cox proportional hazards models were used to calculate HRs and 95% CIs.
Results
Among 232,452 women with over 5,030,196 person-years of follow-up, 315 cases of CD and 392 cases of UC were recorded through 2007 in NHS II and 2008 in NHS I. Compared with never users of oral contraceptives, the multivariate-adjusted HRs for CD were 2.82 (95% CI 1.65 to 4.82) among current users and 1.39 (95% CI 1.05 to 1.85) among past users. The association between oral contraceptives and UC differed according to smoking history (pheterogeneity=0.04). Age at menarche, age at first birth and parity were not associated with risk of UC or CD.
Conclusion
In two large prospective cohorts of US women, oral contraceptive use was associated with risk of CD. The association between oral contraceptive use and UC was limited to women with a history of smoking.
oral contraceptives inflammatory bowel disease, birth control pills crohn disease risk, ulcerative colitis hormonal contraception, reproductive factors ibd women, oral contraceptive use crohn's risk, nurses health study contraception outcomes, hormonal contraception autoimmune disease, birth control pills ulcerative colitis smoking, oral contraceptives gastrointestinal complications, reproductive history inflammatory bowel disease
Cite this article
Khalili, H., Higuchi, L. M., Ananthakrishnan, A., Richter, J., Feskanich, D., fuchs, C., & Chan, A. (2013). Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. *Gut*, *62*(8), 1153-1159. https://doi.org/10.1136/gutjnl-2012-302362
Khalili H, Higuchi LM, Ananthakrishnan A, Richter J, Feskanich D, fuchs C, et al. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut. 2013;62(8):1153-1159. doi:10.1136/gutjnl-2012-302362
Khalili, Hamed, et al. "Oral contraceptives, reproductive factors and risk of inflammatory bowel disease." *Gut*, vol. 62, no. 8, 2013, pp. 1153-1159.
Alonso-Molero J et al., 2022Menopause (New York, N.Y.)
Objective: To extend knowledge about the long-term use of hormones in hormone therapy or oral contraception as prognostic factors in breast cancer.
Methods: The MCC-Spain project is a cohort of 1,685 ...
Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side EffectsGeneral OB/GYN > Epidemiology > Trends
To investigate the sociological, environmental, and economic impact of hormonally active contraceptives, a series of comprehensive literature surveys were employed. Sociological effects are discussed ...
Contraception/Comparison > Side Effects > Hormonal ContraceptionContraception/Comparison > FABM vs Hormonal > Side EffectsEthics/Philosophy > Informed Consent > Reproductive Procedures
Anderl C et al., 2021
Open Access
Journal of Child Psychology and Psychiatry, and Allied Disciplines
Background: Because of the widespread use of oral contraceptives (OCs) and the devastating effects of depression both on an individual and a societal level, it is crucial to understand the nature of t...
Skovlund CW et al., 2017The American Journal of Psychiatry
Objective: The purpose of this study was to assess the relative risk of suicide attempt and suicide in users of hormonal contraception.
Method: The authors assessed associations between hormonal contr...